Tctc Holdings, LLC Reata Pharmaceuticals Inc Transaction History

Tctc Holdings, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$24.12 - $39.6 $1,447 - $2,376	-60 Reduced 0.29%	20,982 $687,000
Q4 2021 Feb 09, 2022	BUY	$25.61 - $110.96 $1,536 - $6,657	60 Added 0.29%	21,042 $555,000
Q2 2020 Aug 12, 2020	SELL	$126.3 - $176.56 $2.65 Million - $3.7 Million	-20,982 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $1.09 Million - $2.14 Million	20,982 New	20,982 $1.79 Million
Q3 2017 Nov 14, 2017	SELL	$26.29 - $31.88 $551,616 - $668,906	-20,982 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	20,982	20,982 $664,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Tctc Holdings, LLC with notifications on news.